Stay on top of the latest news and blogs by subscribing to our mailing list
| Biomedicum, Helsinki
14.04.2023 | 23:45
Picture source: GeneCellNano website.
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers, and diagnostics for diseases with unmet clinical needs. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian, and bladder cancer. GeneCellNano 2nd Annual Meeting is funded by the Academy of Finland and itgathers together participants from academic host institutions and industrial collaborators.
Timegate will be having a booth and our Senior Application Specialist Jacopo Zini will also be giving a speech at the event. Follow our LinkedIn and Twitter for more information!